secwatch.observer — SEC 8-K summary
======================================

Issuer:     Thorne Healthtech, Inc. (—)
CIK:        0001844280
Form:       8-K
Filed at:   2023-06-13T23:59:59+00:00
Accession:  0000950170-23-027694
Event type: regulatory
Sentiment:  negative
Materiality: 0.55
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Thorne HealthTech receives Nasdaq non-compliance notice for audit committee composition
--------------------------------------------------------------------------------

- Nasdaq notified Thorne on June 6, 2023 of non-compliance with Listing Rule 5605(c)(2)(A) requiring three independent audit committee members.
- Audit Committee has two independent directors after CFO Saloni Varma resigned from the committee effective April 1, 2023.
- Cure period runs until September 28, 2023; company plans to appoint an additional independent director.
- Notice has no immediate effect on THRN common stock listing or trading on Nasdaq Global Select Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844280/000095017023027694/0000950170-23-027694-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844280/000095017023027694/thrn-20230606.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-027694

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer